<DOC>
	<DOCNO>NCT02254148</DOCNO>
	<brief_summary>To assess influence BI 187004 kinetics cytochrome P450 ( CYP ) P glycoprotein ( P-gp ) probe drug mean predict drug-drug interaction .</brief_summary>
	<brief_title>The Effect BI 187004 Pharmacokinetics Cytochrome P450 Substrates ( Caffeine , Warfarin , Omeprazole , Metoprolol Midazolam ) P Glycoprotein Substrate ( Digoxin )</brief_title>
	<detailed_description />
	<mesh_term>Digoxin</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<mesh_term>Caffeine</mesh_term>
	<mesh_term>Krestin</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Inclusion criterion : 1. healthy male subject 2. age 18 55 year 3. body mass index 18.5 29.9 kg/m2 4 . Subjects must able understand comply study requirement Exclusion criterion : 1 . Any finding medical examination ( include BP , PR ECG ) deviate normal judge clinically relevant investigator 2 . Repeated measurement systolic blood pressure outside range 90 140 mmHg , diastolic blood pressure outside range 50 90 mmHg , pulse rate outside range 50 90 bpm 3 . Any laboratory value outside reference range investigator considers clinical relevance 4 . Any evidence concomitant disease judge clinically relevant investigator 5 . Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder 6 . Cholecystectomy and/or surgery gastrointestinal tract could interfere pharmacokinetics trial medication ( except appendectomy simple hernia repair ) 7 . Diseases central nervous system ( include limit kind seizure stroke ) , relevant neurological psychiatric disorder</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>